Treatment of Bacterial Conjunctivitis in Infants
For mild to moderate bacterial conjunctivitis in infants, treat with a 5-7 day course of broad-spectrum topical antibiotics (erythromycin 0.5% ointment, azithromycin 1.5%, or fluoroquinolone drops), but if gonococcal or chlamydial infection is suspected based on severe purulent discharge or timing of onset, immediately obtain cultures and initiate systemic antibiotics. 1
Clinical Decision Algorithm
Step 1: Determine Severity and Likely Pathogen
Timing of onset is critical:
- Days 1-7 after birth with severe purulent discharge → Suspect gonococcal ophthalmia neonatorum 1
- Days 5-19 after birth with mucopurulent/blood-stained discharge → Suspect chlamydial conjunctivitis 1
- Mild conjunctivitis with minimal discharge → Likely non-gonococcal bacterial infection 1
Red flags requiring immediate systemic treatment:
- Copious purulent discharge with marked eyelid edema
- Preauricular lymphadenopathy
- Any corneal involvement (infiltrate, ulcer, opacity)
- Maternal history of sexually transmitted infections 1
Step 2: Treatment Based on Etiology
Gonococcal Conjunctivitis (Ophthalmia Neonatorum)
Systemic treatment is mandatory - topical therapy alone is inadequate:
- Ceftriaxone 25-50 mg/kg IV or IM single dose (max 250 mg) 1
- Add saline lavage for comfort and faster resolution 1
- If corneal involvement present, add topical antibiotics as for bacterial keratitis 1
- Daily follow-up required until resolution 1
- Consider sexual abuse in all pediatric cases 1
Critical pitfall: Rule out Neisseria meningitidis before concluding gonococcal infection 1
Chlamydial Conjunctivitis
Systemic therapy is required because >50% of infants have concurrent nasopharyngeal, genital, or pulmonary infection 1:
First-line options:
- Erythromycin base or ethylsuccinate 50 mg/kg/day PO divided into 4 doses for 14 days 1
- Azithromycin suspension 20 mg/kg/day PO once daily for 3 days 1
Important caveat: Erythromycin in infants <6 weeks carries risk of infantile hypertrophic pyloric stenosis - monitor for feeding intolerance, projectile vomiting 1. Treatment failure occurs in up to 19% of cases, requiring re-evaluation after completion 1.
Topical antibiotics provide no additional benefit to systemic therapy 1
Mild to Moderate Non-Gonococcal/Non-Chlamydial Bacterial Conjunctivitis
Topical antibiotic options (5-7 day course):
- Erythromycin 0.5% ointment (also used for neonatal prophylaxis) 1
- Azithromycin 1.5% drops (1 drop twice daily for 3 days) 2
- Fluoroquinolones (ciprofloxacin, moxifloxacin, gatifloxacin) - now FDA-approved for all ages including neonates 3
- Tobramycin 0.3% (though resistance increasing in NICU settings) 4
No single antibiotic is superior - choose based on convenience and cost 1. The evidence shows azithromycin 1.5% produces faster resolution of discharge (by day 3) with better parent satisfaction due to simpler dosing compared to tobramycin 2.
Alternative when antibiotics unavailable: Povidone-iodine 1.25% ophthalmic solution may be equally effective 1
Step 3: Special Considerations for High-Risk Infants
NICU patients with low birth weight/gestational age:
- Higher incidence of gram-negative conjunctivitis (especially Klebsiella pneumoniae, Serratia marcescens) 1, 4
- Often resistant to gentamicin 1
- May require fortified vancomycin drops (for MRSA) or culture-guided therapy 1, 4
- Coagulase-negative staphylococci most common overall (52.9% of NICU cases) 4
Step 4: Follow-Up Strategy
Gonococcal/Chlamydial: Daily visits until resolution with interval history, visual acuity, slit-lamp exam 1
Other bacterial conjunctivitis: Return in 3-4 days if no improvement 1
Chlamydial cases: Re-evaluate after treatment completion due to 19% failure rate 1
Key Clinical Pearls
- Mild bacterial conjunctivitis is self-limited in immunocompetent infants, but topical antibiotics shorten duration by 2-5 days and reduce transmissibility 1
- Lid hygiene alone cures >50% of mild cases within 32 days 5
- Dacryocystitis complicates 17% of neonatal conjunctivitis cases and may cause treatment failure 5
- Sexual abuse must be considered when gonococcal or chlamydial infection identified in children 1
- Maternal/partner treatment required for sexually transmitted pathogens 1, 6